168 related articles for article (PubMed ID: 27987595)
1. Tumour size reduction after the first chemotherapy-course and outcomes of chemoradiotherapy in limited disease small-cell lung cancer.
Halvorsen TO; Herje M; Levin N; Bremnes RM; Brustugun OT; Fløtten Ø; Kaasa S; Sundstrøm S; Grønberg BH
Lung Cancer; 2016 Dec; 102():9-14. PubMed ID: 27987595
[TBL] [Abstract][Full Text] [Related]
2. Randomized phase II trial comparing twice daily hyperfractionated with once daily hypofractionated thoracic radiotherapy in limited disease small cell lung cancer.
Grønberg BH; Halvorsen TO; Fløtten Ø; Brustugun OT; Brunsvig PF; Aasebø U; Bremnes RM; Tollåli T; Hornslien K; Aksnessæther BY; Liaaen ED; Sundstrøm S;
Acta Oncol; 2016 May; 55(5):591-7. PubMed ID: 26494411
[TBL] [Abstract][Full Text] [Related]
3. Duration of Twice-Daily Thoracic Radiotherapy and Time From the Start of Any Treatment to the End of Chest Irradiation as Significant Predictors of Outcomes in Limited-Disease Small-Cell Lung Cancer.
Morimoto M; Okishio K; Akira M; Omachi N; Tamiya A; Asami K; Kawaguchi T; Atagi S
Clin Lung Cancer; 2017 Mar; 18(2):e117-e127. PubMed ID: 28340925
[TBL] [Abstract][Full Text] [Related]
4. Comorbidity and outcomes of concurrent chemo- and radiotherapy in limited disease small cell lung cancer.
Halvorsen TO; Sundstrøm S; Fløtten Ø; Brustugun OT; Brunsvig P; Aasebø U; Bremnes RM; Kaasa S; Grønberg BH
Acta Oncol; 2016 Nov; 55(11):1349-1354. PubMed ID: 27549509
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
Han JY; Cho KH; Lee DH; Kim HY; Kim EA; Lee SY; Lee JS
J Clin Oncol; 2005 May; 23(15):3488-94. PubMed ID: 15908658
[TBL] [Abstract][Full Text] [Related]
6. Temporal lung tumor volume changes in small-cell lung cancer patients undergoing chemoradiotherapy.
Yee D; Rathee S; Robinson D; Murray B
Int J Radiat Oncol Biol Phys; 2011 May; 80(1):142-7. PubMed ID: 20646851
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic effects and prognostic factors for the limited-stage small cell lung cancer treated with multidisciplinary therapy].
Dong XJ; Wang MZ; Zhong W; Zhang L; Zhang XT; Zhao J; Xia Y; Li LY
Zhonghua Zhong Liu Za Zhi; 2012 Mar; 34(3):216-21. PubMed ID: 22780978
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin and etoposide chemotherapy combined with early concurrent twice-daily thoracic radiotherapy for limited-disease small cell lung cancer in elderly patients.
Okamoto K; Okamoto I; Takezawa K; Tachibana I; Fukuoka M; Nishimura Y; Nakagawa K
Jpn J Clin Oncol; 2010 Jan; 40(1):54-9. PubMed ID: 19837690
[TBL] [Abstract][Full Text] [Related]
9. Survival in Limited Disease Small Cell Lung Cancer According to N3 Lymph Node Involvement.
Valan CD; Slagsvold JE; Halvorsen TO; Herje M; Bremnes RM; Brunsvig PF; Brustugun OT; Fløtten Ø; Levin N; Sundstrøm SH; Grønberg BH
Anticancer Res; 2018 Feb; 38(2):871-876. PubMed ID: 29374714
[TBL] [Abstract][Full Text] [Related]
10. Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer.
Sun JM; Ahn YC; Choi EK; Ahn MJ; Ahn JS; Lee SH; Lee DH; Pyo H; Song SY; Jung SH; Jo JS; Jo J; Sohn HJ; Suh C; Lee JS; Kim SW; Park K
Ann Oncol; 2013 Aug; 24(8):2088-92. PubMed ID: 23592701
[TBL] [Abstract][Full Text] [Related]
11. Timing of thoracic radiotherapy in limited stage small cell lung cancer: results of early versus late irradiation from a single institution in Turkey.
Bayman E; Etiz D; Akcay M; Ak G
Asian Pac J Cancer Prev; 2014; 15(15):6263-7. PubMed ID: 25124609
[TBL] [Abstract][Full Text] [Related]
12. 70 Gy thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: analysis of Cancer and Leukemia Group B study 39808.
Bogart JA; Herndon JE; Lyss AP; Watson D; Miller AA; Lee ME; Turrisi AT; Green MR;
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):460-8. PubMed ID: 15145163
[TBL] [Abstract][Full Text] [Related]
13. Effects of thoracic radiotherapy timing and duration on progression-free survival in limited-stage small cell lung cancer.
Zhao S; Zhou T; Ma S; Zhao Y; Zhan J; Fang W; Yang Y; Hou X; Zhang Z; Chen G; Zhang Y; Huang Y; Zhang L
Cancer Med; 2018 Sep; 7(9):4208-4216. PubMed ID: 30019533
[TBL] [Abstract][Full Text] [Related]
14. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
[TBL] [Abstract][Full Text] [Related]
15. Early CT and FDG-metabolic tumour volume changes show a significant correlation with survival in stage I-III small cell lung cancer: a hypothesis generating study.
van Loon J; Offermann C; Ollers M; van Elmpt W; Vegt E; Rahmy A; Dingemans AM; Lambin P; De Ruysscher D
Radiother Oncol; 2011 May; 99(2):172-5. PubMed ID: 21571382
[TBL] [Abstract][Full Text] [Related]
16. Final report of a prospective randomized study on thoracic radiotherapy target volume for limited-stage small cell lung cancer with radiation dosimetric analyses.
Hu X; Bao Y; Xu YJ; Zhu HN; Liu JS; Zhang L; Guo Y; Jin Y; Wang J; Ma HL; Xu XL; Song ZB; Tang HR; Peng F; Fang M; Kong Y; Chen MY; Dong BQ; Zhu L; Yu C; Yu XM; Hong W; Fan Y; Zhang YP; Chen PC; Zhao Q; Jiang YH; Zhou XM; Chen QX; Sun WY; Mao WM; Chen M
Cancer; 2020 Feb; 126(4):840-849. PubMed ID: 31714592
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
Misumi Y; Okamoto H; Sasaki J; Masuda N; Ishii M; Shimokawa T; Hosomi Y; Okuma Y; Nagamata M; Ogura T; Kato T; Sata M; Otani S; Takakura A; Minato K; Miura Y; Yokoyama T; Takata S; Naoki K; Watanabe K
BMC Cancer; 2017 May; 17(1):377. PubMed ID: 28549414
[TBL] [Abstract][Full Text] [Related]
18. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.
van Loon J; De Ruysscher D; Wanders R; Boersma L; Simons J; Oellers M; Dingemans AM; Hochstenbag M; Bootsma G; Geraedts W; Pitz C; Teule J; Rhami A; Thimister W; Snoep G; Dehing-Oberije C; Lambin P
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):329-36. PubMed ID: 19782478
[TBL] [Abstract][Full Text] [Related]
19. Impact of induction chemotherapy on estimated risk of radiation pneumonitis in small cell lung cancer.
Amin NP; Miften M; Kavanagh B; Raben D; Camidge DR; Thornton D; Rochford N; Gaspar LE
J Thorac Oncol; 2011 Sep; 6(9):1553-62. PubMed ID: 21642862
[TBL] [Abstract][Full Text] [Related]
20. Etoposide plus cisplatin followed by concurrent chemo-radiotherapy and irinotecan plus cisplatin for patients with limited-stage small cell lung cancer: A multicenter phase II study.
Xenidis N; Kotsakis A; Kalykaki A; Christophyllakis Ch; Giassas S; Kentepozidis N; Polyzos A; Chelis L; Vardakis N; Vamvakas L; Georgoulias V; Kakolyris S
Lung Cancer; 2010 Jun; 68(3):450-4. PubMed ID: 19783319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
